Fundz

Naveris, Inc. Raises $51 Million To Advance Commercialization Of Navdx

PRIVATESep 19, 2022

Amount Raised

$51 Million

Round Type

Funding Round

WalthamInformation TechnologyBiotechnologyHealth Care

Description

Naveris, Inc., a commercial-stage life sciences company dedicated to improving patient care through earlier detection of viral-driven cancers, today announced a $33.4 million expansion of its Series A financing, bringing the total investment in Naveris to $51 million. The financing was led by Gurnet Point Capital, joined by TechU Ventures and BrightEdge, the impact and venture capital arm of the American Cancer Society.

Quick answer

Naveris raised $51 Million in a Funding Round round, dated September 19, 2022. Naveris is based in Waltham, Massachusetts, United States.

How much did Naveris raise?
Naveris raised $51 Million in a Funding Round round on September 19, 2022.
What does Naveris do?
Founded in 2017, Naveris is a privately held biotechnology company with facilities in Massachusetts and North Carolina.
Where is Naveris based and how big is it?
Naveris is based in Waltham, Massachusetts, United States.
Who are the decision-makers at Naveris?
Fundz holds 1 contact at Naveris, including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Naveris that raised within 45 days of this round, from Fundz verified event records.

  • Cerus raised an undisclosed amount (Grant) on November 2, 2022.
  • Zenas BioPharma raised $184M on November 2, 2022.
  • Enzyre raised an undisclosed amount (Series A) on November 2, 2022.
  • Carta Healthcare raised $20M (Series B) on November 2, 2022.
  • Biocoat raised an undisclosed amount on November 2, 2022.
  • Jnana Therapeutics Inc. raised $60M on November 2, 2022.

Who to call at Naveris, and when

A new round usually means Naveris is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Naveris raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Naveris, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Naveris. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Naveris

Location

35 GATEHOUSE DRIVE

Waltham, Massachusetts, United States

About

Founded in 2017, Naveris is a privately held biotechnology company with facilities in Massachusetts and North Carolina. The company’s mission is to improve outcomes for the millions of people at risk of developing viral cancers through novel molecular diagnostics that enable earlier cancer detection. Naveris’ clinical laboratory is certified for high complexity testing under CLIA, and is accredited by the College of American Pathologists and the New York State Department of Health Wadsworth Center. For more information, please visit www.naveris.com or email contact@naveris.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Naveris raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsPiyush G., Executive Officer, Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Naveris's next move

See what Strategic adds

Naveris raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.